| This article has been cited by |
| 1 | A Rare Case of Life-Threatening Extensive Mucocutaneous Adverse Reaction Induced by Docetaxel in a Breast Cancer Patient: Toxic Epidermal Necrolysis, a Case Report with Review of Literature | |
| Shiv Prasad Shrivastava,Aditya Elhence,Prutha Jinwala,Shashank Bansal,Prakash Chitalkar,Shweta Bhatnagar,Rajesh Patidar,Vikas Asati |
| Indian Journal of Medical and Paediatric Oncology.2022;43(03)318 |
| [DOI] |
|
| 2 | A Rare Case of Life-Threatening Extensive Mucocutaneous Adverse Reaction Induced by Docetaxel in a Breast Cancer Patient: Toxic Epidermal Necrolysis, a Case Report with Review of Literature | |
| Avinash Gupta,Mark Middleton |
| Indian Journal of Medical and Paediatric Oncology.2011;33(03)935 |
| [DOI] |
|
| 3 | Dermatologic adverse effects of breast cancer chemotherapy: a longitudinal prospective observational study with a review of literature | |
| Narges Alizadeh,Seyyed Hossein Mirpour,Abbas Darjani,Rana Rafiei,Elahe Rafiei,Maryam Mohammadhoseini |
| International Journal of Dermatology.2020;59(7)822 |
| [DOI] |
|
| 4 | Weekly Paclitaxel given concurrently with Durvalumab has a favorable safety profile in triple-negative metastatic breast cancer | |
| Hazem Ghebeh,Adher Al-Sayed,Riham Eiada,Leilani Cabangon,Dahish Ajarim,Kausar Suleman,Asma Tulbah,Taher Al-Tweigeri |
| Scientific Reports.2021;11(1)822 |
| [DOI] |
|
